These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3277401)

  • 1. Complications and monitoring of OKT3 therapy.
    Thistlethwaite JR; Stuart JK; Mayes JT; Gaber AO; Woodle S; Buckingham MR; Stuart FP
    Am J Kidney Dis; 1988 Feb; 11(2):112-9. PubMed ID: 3277401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexposure to OKT3 in renal allograft recipients.
    Mayes JT; Thistlethwaite JR; Stuart JK; Buckingham MR; Stuart FP
    Transplantation; 1988 Feb; 45(2):349-53. PubMed ID: 3278428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3.
    Goldstein G; Fuccello AJ; Norman DJ; Shield CF; Colvin RB; Cosimi AB
    Transplantation; 1986 Nov; 42(5):507-11. PubMed ID: 3538536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful retreatment of allograft rejection with OKT3.
    First MR; Schroeder TJ; Hurtubise PE; Mansour ME; Penn I; Munda R; Balistreri WF; Alexander JW; Melvin DB; Fidler JP
    Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
    Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
    Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial aseptic meningitis associated with administration of OKT3.
    Martin MA; Massanari RM; Nghiem DD; Smith JL; Corry RJ
    JAMA; 1988 Apr; 259(13):2002-5. PubMed ID: 3126308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients.
    Waid TH; Lucas BA; Thompson JS; Brown SA; Munch L; Prebeck RJ; Jezek D
    Transplantation; 1992 Jan; 53(1):80-6. PubMed ID: 1531095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.
    Norman DJ; Shield CF; Barry J; Bennett WM; Henell K; Kimball J; Funnell B; Hubert B
    Am J Kidney Dis; 1988 Feb; 11(2):107-10. PubMed ID: 3277400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.
    Birkeland SA; Bach JF; Chatenoud L; Jørgensen KA; Strate M; Elbirk A; Rohr N; Svendsen V
    Transplant Proc; 1990 Feb; 22(1):221-2. PubMed ID: 2106740
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI; Cohen D; Stegall MD; Hardy MA
    Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningism in a ten-month-old infant during OKT3 therapy.
    Rizzo JD; Rowe SA
    J Heart Transplant; 1990; 9(6):727-8. PubMed ID: 2126036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH; Lucas BA; Thompson JS; McKeown JW; Brown S; Kryscio R; Skeeters LJ
    Transplantation; 1997 Jul; 64(2):274-81. PubMed ID: 9256187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
    Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation.
    Oh CS; Stratta RJ; Fox BC; Sollinger HW; Belzer FO; Maki DG
    Transplantation; 1988 Jan; 45(1):68-73. PubMed ID: 3276066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM; McDiarmid SV; Hiatt JR; Brems JJ; Colonna JO; Klein AS; Ashizawa T; Hart J; Lewin K; Goldstein LI
    Transplantation; 1989 Jan; 47(1):82-8. PubMed ID: 2521409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent.
    Vigeral P; Chkoff N; Chatenoud L; Campos H; Lacombe M; Droz D; Goldstein G; Bach JF; Kreis H
    Transplantation; 1986 Jun; 41(6):730-3. PubMed ID: 3520988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
    Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.